Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.38 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.37 |
| ▸ | ALKBH2 | Q6NS38 | 1/20 | 0.36 |
| ▸ | ALKBH3 | Q96Q83 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29587417 | 1.00 | SCN9A (0.38) | SCN9ABCAT1ALKBH2ALKBH3FTO | |
| SCHEMBL24313726 | 0.88 | PTGER4 (0.36) | SCN9APTGER4 | |
| SCHEMBL31723099 | 0.88 | PTGER4 (0.36) | SCN9APTGER4 | |
| SCHEMBL24313796 | 0.87 | RBP4 (0.42) | BCAT1PTGER4 | |
| SCHEMBL24314242 | 0.84 | PTGER4 (0.37) | SCN9AAGTR1PTGER4 | |
| SCHEMBL29587615 | 0.84 | PTGER4 (0.37) | SCN9AAGTR1PTGER4 | |
| SCHEMBL29588225 | 0.83 | PTGER4 (0.38) | SCN9AAGTR1PTGER4 | |
| SCHEMBL24313769 | 0.83 | PTGER4 (0.38) | SCN9AAGTR1PTGER4 | |
| SCHEMBL22588199 | 0.83 | BCAT1 (0.38) | BCAT1ALKBH2ALKBH3FTOAGTR1 | |
| SCHEMBL29588075 | 0.82 | HIF1A (0.37) | BCAT1ALKBH2ALKBH3FTOPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081842-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | THE BROAD INSTITUTE, INC. (US) | 2022-04-21 | — | — | WO | disclosed |